nodes	percent_of_prediction	percent_of_DWPC	metapath
Vismodegib—skin cancer—germ cell cancer	0.644	1	CtDrD
Vismodegib—ABCG2—Dactinomycin—germ cell cancer	0.042	0.153	CbGbCtD
Vismodegib—CYP2C8—Ifosfamide—germ cell cancer	0.0264	0.0964	CbGbCtD
Vismodegib—ABCG2—Cisplatin—germ cell cancer	0.0241	0.0881	CbGbCtD
Vismodegib—ABCG2—Etoposide—germ cell cancer	0.0237	0.0865	CbGbCtD
Vismodegib—CYP2C19—Ifosfamide—germ cell cancer	0.0221	0.0809	CbGbCtD
Vismodegib—CYP2C9—Ifosfamide—germ cell cancer	0.0184	0.0673	CbGbCtD
Vismodegib—ABCG2—Methotrexate—germ cell cancer	0.0156	0.0572	CbGbCtD
Vismodegib—ABCB1—Dactinomycin—germ cell cancer	0.0151	0.0553	CbGbCtD
Vismodegib—CYP2C8—Etoposide—germ cell cancer	0.0126	0.0461	CbGbCtD
Vismodegib—ALB—Methotrexate—germ cell cancer	0.0108	0.0394	CbGbCtD
Vismodegib—CYP3A4—Ifosfamide—germ cell cancer	0.0107	0.0391	CbGbCtD
Vismodegib—ABCB1—Vinblastine—germ cell cancer	0.00948	0.0346	CbGbCtD
Vismodegib—CYP2C9—Cisplatin—germ cell cancer	0.00895	0.0327	CbGbCtD
Vismodegib—ABCB1—Cisplatin—germ cell cancer	0.00869	0.0318	CbGbCtD
Vismodegib—ABCB1—Etoposide—germ cell cancer	0.00854	0.0312	CbGbCtD
Vismodegib—SHH—skull—germ cell cancer	0.00612	0.114	CbGeAlD
Vismodegib—CYP3A4—Vinblastine—germ cell cancer	0.00568	0.0207	CbGbCtD
Vismodegib—ABCB1—Methotrexate—germ cell cancer	0.00564	0.0206	CbGbCtD
Vismodegib—SHH—telencephalic ventricle—germ cell cancer	0.00512	0.0953	CbGeAlD
Vismodegib—CYP3A4—Etoposide—germ cell cancer	0.00512	0.0187	CbGbCtD
Vismodegib—SHH—appendage—germ cell cancer	0.00455	0.0847	CbGeAlD
Vismodegib—SHH—skin epidermis—germ cell cancer	0.00378	0.0705	CbGeAlD
Vismodegib—CYP2C9—cardial valve—germ cell cancer	0.00363	0.0675	CbGeAlD
Vismodegib—SHH—embryo—germ cell cancer	0.00151	0.0281	CbGeAlD
Vismodegib—SHH—brainstem—germ cell cancer	0.00138	0.0258	CbGeAlD
Vismodegib—Sorafenib—KIT—germ cell cancer	0.00128	1	CrCbGaD
Vismodegib—ABCG2—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.00127	0.134	CbGpPWpGaD
Vismodegib—SHH—telencephalon—germ cell cancer	0.00123	0.0229	CbGeAlD
Vismodegib—SHH—skin of body—germ cell cancer	0.00117	0.0218	CbGeAlD
Vismodegib—SMO—trigeminal ganglion—germ cell cancer	0.00109	0.0204	CbGeAlD
Vismodegib—SMO—embryo—germ cell cancer	0.00106	0.0197	CbGeAlD
Vismodegib—CYP2C19—urine—germ cell cancer	0.00101	0.0188	CbGeAlD
Vismodegib—SHH—Dopaminergic Neurogenesis—SOX2—germ cell cancer	0.00101	0.107	CbGpPWpGaD
Vismodegib—SHH—midbrain—germ cell cancer	0.000882	0.0164	CbGeAlD
Vismodegib—SHH—bone marrow—germ cell cancer	0.000865	0.0161	CbGeAlD
Vismodegib—SHH—spinal cord—germ cell cancer	0.000861	0.016	CbGeAlD
Vismodegib—SMO—skin of body—germ cell cancer	0.00082	0.0153	CbGeAlD
Vismodegib—CYP2C9—urine—germ cell cancer	0.000782	0.0146	CbGeAlD
Vismodegib—SHH—endocrine gland—germ cell cancer	0.000775	0.0144	CbGeAlD
Vismodegib—SHH—head—germ cell cancer	0.000765	0.0142	CbGeAlD
Vismodegib—ABCG2—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.000728	0.0769	CbGpPWpGaD
Vismodegib—SMO—uterus—germ cell cancer	0.000712	0.0133	CbGeAlD
Vismodegib—SMO—pituitary gland—germ cell cancer	0.0007	0.013	CbGeAlD
Vismodegib—ABCB1—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.000685	0.0724	CbGpPWpGaD
Vismodegib—SHH—cerebellum—germ cell cancer	0.000683	0.0127	CbGeAlD
Vismodegib—SMO—medulla oblongata—germ cell cancer	0.000675	0.0126	CbGeAlD
Vismodegib—SMO—adrenal gland—germ cell cancer	0.000625	0.0116	CbGeAlD
Vismodegib—SMO—midbrain—germ cell cancer	0.000617	0.0115	CbGeAlD
Vismodegib—SMO—spinal cord—germ cell cancer	0.000602	0.0112	CbGeAlD
Vismodegib—CYP3A4—urine—germ cell cancer	0.000596	0.0111	CbGeAlD
Vismodegib—SMO—female gonad—germ cell cancer	0.000583	0.0109	CbGeAlD
Vismodegib—SHH—brain—germ cell cancer	0.000554	0.0103	CbGeAlD
Vismodegib—SMO—endocrine gland—germ cell cancer	0.000542	0.0101	CbGeAlD
Vismodegib—SMO—head—germ cell cancer	0.000535	0.00996	CbGeAlD
Vismodegib—SMO—testis—germ cell cancer	0.000517	0.00962	CbGeAlD
Vismodegib—SHH—Differentiation Pathway—FGF4—germ cell cancer	0.000508	0.0537	CbGpPWpGaD
Vismodegib—SMO—cerebellum—germ cell cancer	0.000477	0.00889	CbGeAlD
Vismodegib—Neoplasm malignant—Ifosfamide—germ cell cancer	0.000465	0.0257	CcSEcCtD
Vismodegib—Amenorrhoea—Ifosfamide—germ cell cancer	0.000452	0.025	CcSEcCtD
Vismodegib—Ageusia—Cisplatin—germ cell cancer	0.000423	0.0234	CcSEcCtD
Vismodegib—SHH—Differentiation Pathway—KITLG—germ cell cancer	0.000417	0.0441	CbGpPWpGaD
Vismodegib—ABCB1—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.000393	0.0416	CbGpPWpGaD
Vismodegib—ABCG2—HIF-2-alpha transcription factor network—POU5F1—germ cell cancer	0.000391	0.0414	CbGpPWpGaD
Vismodegib—SMO—brain—germ cell cancer	0.000388	0.00722	CbGeAlD
Vismodegib—SMO—lymph node—germ cell cancer	0.000375	0.00698	CbGeAlD
Vismodegib—Azotaemia—Methotrexate—germ cell cancer	0.000353	0.0195	CcSEcCtD
Vismodegib—Phosphatase alkaline increased—Etoposide—germ cell cancer	0.000314	0.0174	CcSEcCtD
Vismodegib—SHH—Ectoderm Differentiation—SOX2—germ cell cancer	0.000297	0.0314	CbGpPWpGaD
Vismodegib—Pain in extremity—Ifosfamide—germ cell cancer	0.000288	0.016	CcSEcCtD
Vismodegib—ABCG2—trigeminal ganglion—germ cell cancer	0.000286	0.00533	CbGeAlD
Vismodegib—SHH—Differentiation Pathway—KIT—germ cell cancer	0.000285	0.0301	CbGpPWpGaD
Vismodegib—Aspartate aminotransferase increased—Dactinomycin—germ cell cancer	0.000283	0.0157	CcSEcCtD
Vismodegib—ORM1—bone marrow—germ cell cancer	0.000264	0.00492	CbGeAlD
Vismodegib—Weight decreased—Bleomycin—germ cell cancer	0.000264	0.0146	CcSEcCtD
Vismodegib—ORM1—spinal cord—germ cell cancer	0.000263	0.0049	CbGeAlD
Vismodegib—Hypokalaemia—Ifosfamide—germ cell cancer	0.000262	0.0145	CcSEcCtD
Vismodegib—Blood alkaline phosphatase increased—Etoposide—germ cell cancer	0.000262	0.0145	CcSEcCtD
Vismodegib—Breast disorder—Ifosfamide—germ cell cancer	0.00026	0.0144	CcSEcCtD
Vismodegib—Hyponatraemia—Cisplatin—germ cell cancer	0.000249	0.0138	CcSEcCtD
Vismodegib—Alopecia—Vinblastine—germ cell cancer	0.000244	0.0135	CcSEcCtD
Vismodegib—ALB—adrenal gland—germ cell cancer	0.00024	0.00446	CbGeAlD
Vismodegib—ORM1—endocrine gland—germ cell cancer	0.000237	0.00441	CbGeAlD
Vismodegib—Dehydration—Cisplatin—germ cell cancer	0.000231	0.0128	CcSEcCtD
Vismodegib—ABCB1—blood vessel—germ cell cancer	0.000229	0.00426	CbGeAlD
Vismodegib—Hypokalaemia—Cisplatin—germ cell cancer	0.000226	0.0125	CcSEcCtD
Vismodegib—ABCG2—telencephalon—germ cell cancer	0.000225	0.00419	CbGeAlD
Vismodegib—Breast disorder—Cisplatin—germ cell cancer	0.000225	0.0124	CcSEcCtD
Vismodegib—Aspartate aminotransferase increased—Cisplatin—germ cell cancer	0.000224	0.0124	CcSEcCtD
Vismodegib—ABCG2—decidua—germ cell cancer	0.000213	0.00397	CbGeAlD
Vismodegib—Alopecia—Bleomycin—germ cell cancer	0.000206	0.0114	CcSEcCtD
Vismodegib—Hepatic enzyme increased—Methotrexate—germ cell cancer	0.000199	0.011	CcSEcCtD
Vismodegib—ALB—testis—germ cell cancer	0.000198	0.00369	CbGeAlD
Vismodegib—Connective tissue disorder—Ifosfamide—germ cell cancer	0.000196	0.0108	CcSEcCtD
Vismodegib—ALB—Transport of organic anions—AVP—germ cell cancer	0.000195	0.0206	CbGpPWpGaD
Vismodegib—Alopecia—Dactinomycin—germ cell cancer	0.000192	0.0106	CcSEcCtD
Vismodegib—CYP2C8—pituitary gland—germ cell cancer	0.000188	0.00351	CbGeAlD
Vismodegib—ABCG2—uterus—germ cell cancer	0.000187	0.00347	CbGeAlD
Vismodegib—ABCG2—pituitary gland—germ cell cancer	0.000183	0.00341	CbGeAlD
Vismodegib—ABCG2—medulla oblongata—germ cell cancer	0.000177	0.00329	CbGeAlD
Vismodegib—Alopecia—Ifosfamide—germ cell cancer	0.000176	0.00976	CcSEcCtD
Vismodegib—SHH—Hair Follicle Development: Induction (Part 1 of 3)—MYC—germ cell cancer	0.000174	0.0184	CbGpPWpGaD
Vismodegib—Malnutrition—Ifosfamide—germ cell cancer	0.000174	0.00961	CcSEcCtD
Vismodegib—Myalgia—Bleomycin—germ cell cancer	0.000173	0.00957	CcSEcCtD
Vismodegib—CYP2C8—Metapathway biotransformation—NAT9—germ cell cancer	0.000171	0.0181	CbGpPWpGaD
Vismodegib—Decreased appetite—Vinblastine—germ cell cancer	0.000171	0.00945	CcSEcCtD
Vismodegib—Connective tissue disorder—Cisplatin—germ cell cancer	0.000169	0.00935	CcSEcCtD
Vismodegib—Pain—Vinblastine—germ cell cancer	0.000168	0.00929	CcSEcCtD
Vismodegib—Constipation—Vinblastine—germ cell cancer	0.000168	0.00929	CcSEcCtD
Vismodegib—CYP2C19—endocrine gland—germ cell cancer	0.000167	0.00311	CbGeAlD
Vismodegib—SMO—Hair Follicle Development: Induction (Part 1 of 3)—MYC—germ cell cancer	0.000165	0.0175	CbGpPWpGaD
Vismodegib—ORM1—lymph node—germ cell cancer	0.000164	0.00305	CbGeAlD
Vismodegib—ABCG2—adrenal gland—germ cell cancer	0.000164	0.00305	CbGeAlD
Vismodegib—ABCG2—midbrain—germ cell cancer	0.000162	0.00301	CbGeAlD
Vismodegib—Myalgia—Dactinomycin—germ cell cancer	0.000161	0.00893	CcSEcCtD
Vismodegib—Gastrointestinal pain—Vinblastine—germ cell cancer	0.00016	0.00889	CcSEcCtD
Vismodegib—ABCG2—bone marrow—germ cell cancer	0.000158	0.00295	CbGeAlD
Vismodegib—ABCG2—spinal cord—germ cell cancer	0.000158	0.00294	CbGeAlD
Vismodegib—Abdominal pain—Vinblastine—germ cell cancer	0.000155	0.00859	CcSEcCtD
Vismodegib—ABCG2—female gonad—germ cell cancer	0.000153	0.00284	CbGeAlD
Vismodegib—CYP2C19—Metapathway biotransformation—NAT9—germ cell cancer	0.000153	0.0161	CbGpPWpGaD
Vismodegib—Alopecia—Cisplatin—germ cell cancer	0.000152	0.00841	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000151	0.00836	CcSEcCtD
Vismodegib—Malnutrition—Cisplatin—germ cell cancer	0.00015	0.00829	CcSEcCtD
Vismodegib—ALB—brain—germ cell cancer	0.000149	0.00277	CbGeAlD
Vismodegib—Arthralgia—Ifosfamide—germ cell cancer	0.000148	0.00818	CcSEcCtD
Vismodegib—Myalgia—Ifosfamide—germ cell cancer	0.000148	0.00818	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000147	0.00813	CcSEcCtD
Vismodegib—CYP2C8—endocrine gland—germ cell cancer	0.000146	0.00272	CbGeAlD
Vismodegib—Decreased appetite—Bleomycin—germ cell cancer	0.000144	0.00798	CcSEcCtD
Vismodegib—Muscle spasms—Cisplatin—germ cell cancer	0.000144	0.00797	CcSEcCtD
Vismodegib—ALB—lymph node—germ cell cancer	0.000144	0.00267	CbGeAlD
Vismodegib—Pain—Bleomycin—germ cell cancer	0.000142	0.00785	CcSEcCtD
Vismodegib—ABCB1—trigeminal ganglion—germ cell cancer	0.000141	0.00263	CbGeAlD
Vismodegib—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000141	0.0078	CcSEcCtD
Vismodegib—Asthenia—Vinblastine—germ cell cancer	0.000141	0.0078	CcSEcCtD
Vismodegib—CYP2C8—testis—germ cell cancer	0.000139	0.00259	CbGeAlD
Vismodegib—Alopecia—Etoposide—germ cell cancer	0.000139	0.00771	CcSEcCtD
Vismodegib—CYP2C9—Metapathway biotransformation—NAT9—germ cell cancer	0.000139	0.0147	CbGpPWpGaD
Vismodegib—Nervous system disorder—Ifosfamide—germ cell cancer	0.000139	0.00769	CcSEcCtD
Vismodegib—Skin disorder—Ifosfamide—germ cell cancer	0.000138	0.00762	CcSEcCtD
Vismodegib—ABCB1—embryo—germ cell cancer	0.000136	0.00254	CbGeAlD
Vismodegib—ABCG2—testis—germ cell cancer	0.000135	0.00252	CbGeAlD
Vismodegib—Decreased appetite—Dactinomycin—germ cell cancer	0.000134	0.00744	CcSEcCtD
Vismodegib—Diarrhoea—Vinblastine—germ cell cancer	0.000134	0.00744	CcSEcCtD
Vismodegib—Dysgeusia—Etoposide—germ cell cancer	0.000134	0.00743	CcSEcCtD
Vismodegib—Fatigue—Dactinomycin—germ cell cancer	0.000133	0.00738	CcSEcCtD
Vismodegib—Back pain—Etoposide—germ cell cancer	0.000133	0.00734	CcSEcCtD
Vismodegib—Pain—Dactinomycin—germ cell cancer	0.000132	0.00732	CcSEcCtD
Vismodegib—Muscle spasms—Etoposide—germ cell cancer	0.000132	0.0073	CcSEcCtD
Vismodegib—CYP2C9—endocrine gland—germ cell cancer	0.00013	0.00241	CbGeAlD
Vismodegib—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000129	0.00715	CcSEcCtD
Vismodegib—Myalgia—Cisplatin—germ cell cancer	0.000127	0.00705	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000127	0.00701	CcSEcCtD
Vismodegib—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000126	0.007	CcSEcCtD
Vismodegib—ABCG2—cerebellum—germ cell cancer	0.000125	0.00233	CbGeAlD
Vismodegib—Vomiting—Vinblastine—germ cell cancer	0.000125	0.00691	CcSEcCtD
Vismodegib—Breast disorder—Methotrexate—germ cell cancer	0.000123	0.00682	CcSEcCtD
Vismodegib—Decreased appetite—Ifosfamide—germ cell cancer	0.000123	0.00682	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000122	0.00677	CcSEcCtD
Vismodegib—Abdominal pain—Dactinomycin—germ cell cancer	0.000122	0.00677	CcSEcCtD
Vismodegib—Fatigue—Ifosfamide—germ cell cancer	0.000122	0.00676	CcSEcCtD
Vismodegib—Pain—Ifosfamide—germ cell cancer	0.000121	0.00671	CcSEcCtD
Vismodegib—Constipation—Ifosfamide—germ cell cancer	0.000121	0.00671	CcSEcCtD
Vismodegib—ABCB1—retina—germ cell cancer	0.000121	0.00225	CbGeAlD
Vismodegib—Nervous system disorder—Cisplatin—germ cell cancer	0.00012	0.00663	CcSEcCtD
Vismodegib—Asthenia—Bleomycin—germ cell cancer	0.000119	0.00659	CcSEcCtD
Vismodegib—Skin disorder—Cisplatin—germ cell cancer	0.000119	0.00657	CcSEcCtD
Vismodegib—Pruritus—Bleomycin—germ cell cancer	0.000117	0.00649	CcSEcCtD
Vismodegib—Nausea—Vinblastine—germ cell cancer	0.000117	0.00646	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000116	0.00642	CcSEcCtD
Vismodegib—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000116	0.00641	CcSEcCtD
Vismodegib—Abdominal pain—Ifosfamide—germ cell cancer	0.000112	0.0062	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000111	0.00616	CcSEcCtD
Vismodegib—ABCB1—telencephalon—germ cell cancer	0.000111	0.00207	CbGeAlD
Vismodegib—Asthenia—Dactinomycin—germ cell cancer	0.000111	0.00614	CcSEcCtD
Vismodegib—Skin disorder—Etoposide—germ cell cancer	0.000109	0.00602	CcSEcCtD
Vismodegib—Decreased appetite—Cisplatin—germ cell cancer	0.000106	0.00588	CcSEcCtD
Vismodegib—Diarrhoea—Dactinomycin—germ cell cancer	0.000106	0.00586	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000105	0.00584	CcSEcCtD
Vismodegib—Vomiting—Bleomycin—germ cell cancer	0.000105	0.00584	CcSEcCtD
Vismodegib—ABCB1—decidua—germ cell cancer	0.000105	0.00196	CbGeAlD
Vismodegib—Rash—Bleomycin—germ cell cancer	0.000105	0.00579	CcSEcCtD
Vismodegib—Pain—Cisplatin—germ cell cancer	0.000104	0.00578	CcSEcCtD
Vismodegib—CYP2C8—brain—germ cell cancer	0.000104	0.00194	CbGeAlD
Vismodegib—Dermatitis—Bleomycin—germ cell cancer	0.000104	0.00578	CcSEcCtD
Vismodegib—Asthenia—Ifosfamide—germ cell cancer	0.000102	0.00563	CcSEcCtD
Vismodegib—ABCG2—brain—germ cell cancer	0.000102	0.00189	CbGeAlD
Vismodegib—SHH—GPCR ligand binding—OXT—germ cell cancer	0.000101	0.0107	CbGpPWpGaD
Vismodegib—Pruritus—Ifosfamide—germ cell cancer	0.0001	0.00555	CcSEcCtD
Vismodegib—CYP3A4—endocrine gland—germ cell cancer	9.89e-05	0.00184	CbGeAlD
Vismodegib—Nausea—Bleomycin—germ cell cancer	9.85e-05	0.00545	CcSEcCtD
Vismodegib—Vomiting—Dactinomycin—germ cell cancer	9.83e-05	0.00544	CcSEcCtD
Vismodegib—ABCG2—lymph node—germ cell cancer	9.81e-05	0.00183	CbGeAlD
Vismodegib—Rash—Dactinomycin—germ cell cancer	9.75e-05	0.0054	CcSEcCtD
Vismodegib—Decreased appetite—Etoposide—germ cell cancer	9.73e-05	0.00539	CcSEcCtD
Vismodegib—Diarrhoea—Ifosfamide—germ cell cancer	9.69e-05	0.00537	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Etoposide—germ cell cancer	9.66e-05	0.00535	CcSEcCtD
Vismodegib—Fatigue—Etoposide—germ cell cancer	9.65e-05	0.00534	CcSEcCtD
Vismodegib—SMO—GPCR ligand binding—OXT—germ cell cancer	9.59e-05	0.0101	CbGpPWpGaD
Vismodegib—Constipation—Etoposide—germ cell cancer	9.57e-05	0.0053	CcSEcCtD
Vismodegib—Pain—Etoposide—germ cell cancer	9.57e-05	0.0053	CcSEcCtD
Vismodegib—ABCB1—gonad—germ cell cancer	9.26e-05	0.00172	CbGeAlD
Vismodegib—ABCB1—uterus—germ cell cancer	9.2e-05	0.00171	CbGeAlD
Vismodegib—Nausea—Dactinomycin—germ cell cancer	9.18e-05	0.00508	CcSEcCtD
Vismodegib—CYP3A4—Metapathway biotransformation—NAT9—germ cell cancer	9.17e-05	0.00969	CbGpPWpGaD
Vismodegib—Gastrointestinal pain—Etoposide—germ cell cancer	9.15e-05	0.00507	CcSEcCtD
Vismodegib—ABCB1—pituitary gland—germ cell cancer	9.03e-05	0.00168	CbGeAlD
Vismodegib—Vomiting—Ifosfamide—germ cell cancer	9.01e-05	0.00499	CcSEcCtD
Vismodegib—Rash—Ifosfamide—germ cell cancer	8.93e-05	0.00495	CcSEcCtD
Vismodegib—Dermatitis—Ifosfamide—germ cell cancer	8.92e-05	0.00494	CcSEcCtD
Vismodegib—Abdominal pain—Etoposide—germ cell cancer	8.84e-05	0.0049	CcSEcCtD
Vismodegib—Asthenia—Cisplatin—germ cell cancer	8.76e-05	0.00485	CcSEcCtD
Vismodegib—ABCB1—medulla oblongata—germ cell cancer	8.72e-05	0.00162	CbGeAlD
Vismodegib—Nausea—Ifosfamide—germ cell cancer	8.41e-05	0.00466	CcSEcCtD
Vismodegib—ALB—Platelet degranulation—CD9—germ cell cancer	8.38e-05	0.00886	CbGpPWpGaD
Vismodegib—Diarrhoea—Cisplatin—germ cell cancer	8.36e-05	0.00463	CcSEcCtD
Vismodegib—Alopecia—Methotrexate—germ cell cancer	8.34e-05	0.00462	CcSEcCtD
Vismodegib—Malnutrition—Methotrexate—germ cell cancer	8.21e-05	0.00455	CcSEcCtD
Vismodegib—ABCB1—adrenal gland—germ cell cancer	8.07e-05	0.0015	CbGeAlD
Vismodegib—Dysgeusia—Methotrexate—germ cell cancer	8.04e-05	0.00445	CcSEcCtD
Vismodegib—Asthenia—Etoposide—germ cell cancer	8.03e-05	0.00445	CcSEcCtD
Vismodegib—ALB—Response to elevated platelet cytosolic Ca2+—CD9—germ cell cancer	7.99e-05	0.00844	CbGpPWpGaD
Vismodegib—ABCB1—midbrain—germ cell cancer	7.97e-05	0.00148	CbGeAlD
Vismodegib—Back pain—Methotrexate—germ cell cancer	7.94e-05	0.0044	CcSEcCtD
Vismodegib—Pruritus—Etoposide—germ cell cancer	7.92e-05	0.00438	CcSEcCtD
Vismodegib—ABCB1—bone marrow—germ cell cancer	7.81e-05	0.00145	CbGeAlD
Vismodegib—ABCB1—spinal cord—germ cell cancer	7.77e-05	0.00145	CbGeAlD
Vismodegib—Vomiting—Cisplatin—germ cell cancer	7.77e-05	0.0043	CcSEcCtD
Vismodegib—Rash—Cisplatin—germ cell cancer	7.7e-05	0.00426	CcSEcCtD
Vismodegib—Dermatitis—Cisplatin—germ cell cancer	7.69e-05	0.00426	CcSEcCtD
Vismodegib—Diarrhoea—Etoposide—germ cell cancer	7.66e-05	0.00424	CcSEcCtD
Vismodegib—ABCB1—female gonad—germ cell cancer	7.53e-05	0.0014	CbGeAlD
Vismodegib—Nausea—Cisplatin—germ cell cancer	7.25e-05	0.00402	CcSEcCtD
Vismodegib—ALB—Transport of vitamins, nucleosides, and related molecules—AVP—germ cell cancer	7.22e-05	0.00763	CbGpPWpGaD
Vismodegib—Vomiting—Etoposide—germ cell cancer	7.11e-05	0.00394	CcSEcCtD
Vismodegib—Rash—Etoposide—germ cell cancer	7.05e-05	0.00391	CcSEcCtD
Vismodegib—Dermatitis—Etoposide—germ cell cancer	7.05e-05	0.0039	CcSEcCtD
Vismodegib—ABCB1—endocrine gland—germ cell cancer	7e-05	0.0013	CbGeAlD
Vismodegib—Arthralgia—Methotrexate—germ cell cancer	6.99e-05	0.00387	CcSEcCtD
Vismodegib—Myalgia—Methotrexate—germ cell cancer	6.99e-05	0.00387	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	6.94e-05	0.00384	CcSEcCtD
Vismodegib—SHH—GPCR ligand binding—AVP—germ cell cancer	6.93e-05	0.00733	CbGpPWpGaD
Vismodegib—ABCB1—head—germ cell cancer	6.91e-05	0.00129	CbGeAlD
Vismodegib—SHH—Ectoderm Differentiation—MYC—germ cell cancer	6.73e-05	0.00712	CbGpPWpGaD
Vismodegib—ABCB1—testis—germ cell cancer	6.67e-05	0.00124	CbGeAlD
Vismodegib—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	6.67e-05	0.00705	CbGpPWpGaD
Vismodegib—Nausea—Etoposide—germ cell cancer	6.65e-05	0.00368	CcSEcCtD
Vismodegib—SMO—GPCR ligand binding—AVP—germ cell cancer	6.57e-05	0.00694	CbGpPWpGaD
Vismodegib—Nervous system disorder—Methotrexate—germ cell cancer	6.57e-05	0.00364	CcSEcCtD
Vismodegib—Skin disorder—Methotrexate—germ cell cancer	6.51e-05	0.0036	CcSEcCtD
Vismodegib—SHH—Disease—SLC2A3—germ cell cancer	6.51e-05	0.00688	CbGpPWpGaD
Vismodegib—ABCB1—cerebellum—germ cell cancer	6.16e-05	0.00115	CbGeAlD
Vismodegib—Musculoskeletal discomfort—Methotrexate—germ cell cancer	6.11e-05	0.00338	CcSEcCtD
Vismodegib—Dyspepsia—Methotrexate—germ cell cancer	5.9e-05	0.00327	CcSEcCtD
Vismodegib—Decreased appetite—Methotrexate—germ cell cancer	5.83e-05	0.00323	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Methotrexate—germ cell cancer	5.79e-05	0.0032	CcSEcCtD
Vismodegib—Fatigue—Methotrexate—germ cell cancer	5.78e-05	0.0032	CcSEcCtD
Vismodegib—Pain—Methotrexate—germ cell cancer	5.73e-05	0.00317	CcSEcCtD
Vismodegib—Gastrointestinal pain—Methotrexate—germ cell cancer	5.48e-05	0.00303	CcSEcCtD
Vismodegib—Abdominal pain—Methotrexate—germ cell cancer	5.3e-05	0.00293	CcSEcCtD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	5.19e-05	0.00549	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—OXT—germ cell cancer	5.19e-05	0.00549	CbGpPWpGaD
Vismodegib—ABCB1—brain—germ cell cancer	5.01e-05	0.000932	CbGeAlD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	4.92e-05	0.0052	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—OXT—germ cell cancer	4.92e-05	0.0052	CbGpPWpGaD
Vismodegib—ABCB1—lymph node—germ cell cancer	4.84e-05	0.000901	CbGeAlD
Vismodegib—Asthenia—Methotrexate—germ cell cancer	4.81e-05	0.00266	CcSEcCtD
Vismodegib—Pruritus—Methotrexate—germ cell cancer	4.74e-05	0.00263	CcSEcCtD
Vismodegib—Diarrhoea—Methotrexate—germ cell cancer	4.59e-05	0.00254	CcSEcCtD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	4.26e-05	0.00451	CbGpPWpGaD
Vismodegib—Vomiting—Methotrexate—germ cell cancer	4.26e-05	0.00236	CcSEcCtD
Vismodegib—ABCG2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	4.23e-05	0.00447	CbGpPWpGaD
Vismodegib—Rash—Methotrexate—germ cell cancer	4.23e-05	0.00234	CcSEcCtD
Vismodegib—Dermatitis—Methotrexate—germ cell cancer	4.22e-05	0.00234	CcSEcCtD
Vismodegib—ABCG2—Fluoropyrimidine Activity—TP53—germ cell cancer	4.13e-05	0.00437	CbGpPWpGaD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	4.04e-05	0.00427	CbGpPWpGaD
Vismodegib—Nausea—Methotrexate—germ cell cancer	3.98e-05	0.0022	CcSEcCtD
Vismodegib—SHH—Disease—FGF4—germ cell cancer	3.74e-05	0.00395	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—CD9—germ cell cancer	3.72e-05	0.00393	CbGpPWpGaD
Vismodegib—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	3.67e-05	0.00388	CbGpPWpGaD
Vismodegib—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	3.61e-05	0.00381	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—AVP—germ cell cancer	3.56e-05	0.00376	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—AVP—germ cell cancer	3.37e-05	0.00356	CbGpPWpGaD
Vismodegib—ALB—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	3.36e-05	0.00355	CbGpPWpGaD
Vismodegib—SHH—Disease—H2AFZ—germ cell cancer	3.34e-05	0.00353	CbGpPWpGaD
Vismodegib—ALB—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	3.31e-05	0.0035	CbGpPWpGaD
Vismodegib—SHH—Disease—KITLG—germ cell cancer	3.07e-05	0.00324	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—OXT—germ cell cancer	3.07e-05	0.00324	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—OXT—germ cell cancer	2.91e-05	0.00307	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	2.77e-05	0.00293	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	2.73e-05	0.00288	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—FGF4—germ cell cancer	2.62e-05	0.00277	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	2.61e-05	0.00276	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—FGF4—germ cell cancer	2.48e-05	0.00262	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—H2AFZ—germ cell cancer	2.34e-05	0.00247	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	2.29e-05	0.00242	CbGpPWpGaD
Vismodegib—SHH—Disease—FGFR3—germ cell cancer	2.28e-05	0.00241	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—H2AFZ—germ cell cancer	2.22e-05	0.00234	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—KITLG—germ cell cancer	2.15e-05	0.00227	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—AVP—germ cell cancer	2.1e-05	0.00222	CbGpPWpGaD
Vismodegib—SHH—Disease—KIT—germ cell cancer	2.1e-05	0.00221	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—KITLG—germ cell cancer	2.04e-05	0.00215	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—AVP—germ cell cancer	1.99e-05	0.00211	CbGpPWpGaD
Vismodegib—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	1.98e-05	0.0021	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—CD9—germ cell cancer	1.92e-05	0.00203	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	1.71e-05	0.00181	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	1.68e-05	0.00178	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—FGFR3—germ cell cancer	1.6e-05	0.00169	CbGpPWpGaD
Vismodegib—ALB—SLC-mediated transmembrane transport—AVP—germ cell cancer	1.55e-05	0.00164	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—FGFR3—germ cell cancer	1.52e-05	0.0016	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	1.5e-05	0.00158	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	1.47e-05	0.00156	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—KIT—germ cell cancer	1.47e-05	0.00155	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—TP53—germ cell cancer	1.47e-05	0.00155	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	1.45e-05	0.00153	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	1.44e-05	0.00152	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—KIT—germ cell cancer	1.39e-05	0.00147	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—SLC2A3—germ cell cancer	1.3e-05	0.00137	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	1.3e-05	0.00137	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—SLC22A3—germ cell cancer	1.28e-05	0.00135	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—AVP—germ cell cancer	1.28e-05	0.00135	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	1.18e-05	0.00125	CbGpPWpGaD
Vismodegib—SHH—Disease—MYC—germ cell cancer	1.15e-05	0.00122	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—HRAS—germ cell cancer	1.07e-05	0.00113	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—CRABP1—germ cell cancer	1.04e-05	0.0011	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—HRAS—germ cell cancer	1.02e-05	0.00108	CbGpPWpGaD
Vismodegib—SHH—Disease—HRAS—germ cell cancer	9.06e-06	0.000957	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—MYC—germ cell cancer	8.07e-06	0.000853	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—SLC2A3—germ cell cancer	8.05e-06	0.000851	CbGpPWpGaD
Vismodegib—ALB—Metabolism—SLC2A3—germ cell cancer	8e-06	0.000846	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—SLC22A3—germ cell cancer	7.93e-06	0.000838	CbGpPWpGaD
Vismodegib—ALB—Metabolism—SLC22A3—germ cell cancer	7.88e-06	0.000833	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—AVP—germ cell cancer	7.88e-06	0.000833	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—MYC—germ cell cancer	7.65e-06	0.000809	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—SLC2A3—germ cell cancer	7.19e-06	0.000759	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—SLC22A3—germ cell cancer	7.08e-06	0.000748	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—SLC2A3—germ cell cancer	7.01e-06	0.000741	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—SLC22A3—germ cell cancer	6.91e-06	0.00073	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	6.91e-06	0.00073	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	6.68e-06	0.000706	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—TP53—germ cell cancer	6.63e-06	0.000701	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—SLC2A3—germ cell cancer	6.55e-06	0.000692	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CRABP1—germ cell cancer	6.46e-06	0.000683	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—SLC22A3—germ cell cancer	6.45e-06	0.000682	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CRABP1—germ cell cancer	6.43e-06	0.000679	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—HRAS—germ cell cancer	6.34e-06	0.00067	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—TP53—germ cell cancer	6.29e-06	0.000664	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—HRAS—germ cell cancer	6.01e-06	0.000635	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CRABP1—germ cell cancer	5.77e-06	0.00061	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CRABP1—germ cell cancer	5.63e-06	0.000595	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	5.49e-06	0.00058	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CRABP1—germ cell cancer	5.26e-06	0.000556	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—SLC2A3—germ cell cancer	4.32e-06	0.000457	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—SLC22A3—germ cell cancer	4.26e-06	0.00045	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CRABP1—germ cell cancer	3.47e-06	0.000367	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—TP53—germ cell cancer	2.87e-06	0.000303	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—HRAS—germ cell cancer	2.75e-06	0.00029	CbGpPWpGaD
